⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13959147 | 0.76 | — | — | |
| SCHEMBL1126846 | 0.76 | ALDH1A1 (0.44) | — | |
| SCHEMBL2651657 | 0.74 | — | — | |
| SCHEMBL11117617 | 0.72 | — | — | |
| SCHEMBL3297298 | 0.70 | MGAM (0.48) | — | |
| SCHEMBL8838659 | 0.70 | MGAM (0.48) | — | |
| SCHEMBL8210537 | 0.70 | LDHA (0.40) | — | |
| SCHEMBL3236585 | 0.70 | ALDH1A1 (0.42) | — | |
| SCHEMBL10364910 | 0.69 | — | — | |
| SCHEMBL29781019 | 0.69 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109554396-B | Imidazole derivative and gene delivery system thereof | 复旦大学 | 2023-03-17 | — | — | CN | disclosed |
| CN-109554396-A | A kind of imdazole derivatives and its gene pass release system | 复旦大学 | 2019-04-02 | — | — | CN | disclosed |
| US-20190040073-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | SCIFLUOR LIFE SCIENCES, INC. | 2019-02-07 | — | — | US | disclosed |
| US-10118929-B2 | Nonanoic and decanoic acid derivatives and uses thereof | SCIFLUOR LIFE SCIENCES, INC. (US) | 2018-11-06 | — | — | US | disclosed |
| WO-2017189828-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | SCIFLUOR LIFE SCIENCES, INC. (US) | 2017-11-02 | — | — | WO | disclosed |
| US-20170313708-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | FELIQS CORPORATION (JP) | 2017-11-02 | — | — | US | disclosed |
| US-20170313708-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | FELIQS CORPORATION (JP) | 2017-11-02 | — | — | US | disclosed |
| US-20170313708-A1 | NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF | FELIQS CORPORATION (JP) | 2017-11-02 | — | — | US | disclosed |
| US-8304419-B2 | Chemical compounds | GLAXOSMITHKLINE LLC (US) | 2012-11-06 | — | — | US | disclosed |
| US-8119665-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2012-02-21 | — | — | US | disclosed |
| US-20070149499-A1 | Process for preparing beta-lactamase inhibitors | WYETH (US) | 2007-06-28 | — | — | US | disclosed |
| US-20070149499-A1 | Process for preparing beta-lactamase inhibitors | WYETH (US) | 2007-06-28 | — | — | US | disclosed |
| US-20070149499-A1 | Process for preparing beta-lactamase inhibitors | WYETH (US) | 2007-06-28 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| WO-2007024859-A2 | PROCESS FOR PREPARING BETA-LACTAMASE INHIBITORS | WYETH (US) | 2007-03-01 | — | — | WO | disclosed |
| WO-2007024859-A2 | PROCESS FOR PREPARING BETA-LACTAMASE INHIBITORS | WYETH (US) | 2007-03-01 | — | — | WO | disclosed |
| EP-1490343-A1 | NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS | Neurogen Corporation (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20040116424-A1 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION | 2004-06-17 | — | — | US | disclosed |
| WO-2003082829-A1 | NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS | NEUROGEN CORPORATION (US) | 2003-10-09 | — | — | WO | disclosed |